The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 21.05%.However, over the last six months, we can see a weaker performance of 78.85%. Over the last 30 days, the price of ACHL has fallen by 16.46%. And in the last five days, it has surged by 1.47%.
Achilles Therapeutics Plc ADR had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.76 on 02/29/24, while the lowest price during the same period was $0.63 on 08/28/24.
52-week price history of ACHL Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Achilles Therapeutics Plc ADR’s current trading price is -21.59% away from its 52-week high, while its distance from the 52-week low is 119.05%. The stock’s price range for this period has been between $0.63 and $1.76. The Healthcare sector company’s shares saw a trading volume of about 2.68 million for the day, which was higher than the average daily volume of 0.5 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Achilles Therapeutics Plc ADR (ACHL) has experienced a quarterly rise of 32.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 56.72M and boasts a workforce of 215 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0697, with a change in price of +0.6731. Similarly, Achilles Therapeutics Plc ADR recorded 730,532 in trading volume during the last 100 days, posting a change of +95.07%.
ACHL’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ACHL stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.00.
ACHL Stock Stochastic Average
As of today, the raw stochastic average of Achilles Therapeutics Plc ADR over the past 50 days is 94.08%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 90.83%. Additionally, the Stochastic %K and %D values for the company were 91.65% and 92.28%, respectively, over the past 20 days.
